Loading
VR
VRX Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest was filed 05 May 2026.
VRX: what insiders have been doing
VRX belongs to the Health Care sector. Filings by its managers are published through ASX. From 18 October 2025 to 18 October 2026, the disclosure feed for VRX logged 5 filings by 4 insiders.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €31k, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €31k, bought by Bruce Maluish and made public on 5 May 2026 (0.13% of market cap). The buyers include 1 senior executive.
With 5 filings in twelve months, the company is more active than the median of 3 filings across the 2,530 companies we follow on the same exchange. The full history, which starts in 2026, counts 1 purchase against no sales.
The clock since the last published purchase (5 May 2026) now reads 165 days.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€30,649
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleBruce Maluish1 buy
Since the insiders bought
- -42.0%Entry A$0.05 · Close 15 Oct 2026 A$0.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.04
Analyst consensus
Income statement
EBITDA-A$4.1M
Net income-A$4.3M0.0% margin
Valuation
P/Book1.3x
Beta1.42
Balance sheet & cash
Market capA$34.5M
Total debtA$337.2k
Free Cash Flow-A$4.9M
Debt / Equity1%
Profitability & ownership
ROE-20.9%
ROA-12.6%
% insiders25.9%
% institutions13.7%
Last declaration on 20 July 2026
Declarations5 total
ShareASXASX:2924-03112601-6A1334623
ShareASXASX:2924-03106538-6A1332009
694,444 shares@ A$0.0720.13% mcap100.0% of flowShareASXASX:2924-03086816-6A1324169
Canonical exit: 2 Aug 2026 (T+90)
5 of 5 declarations
About VRX
VRX is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions for patient well-being.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
